Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Feeding practices and patent ductus arteriosus ligation preferences-are they related?

Jhaveri N, Soll RF, Clyman RI.

Am J Perinatol. 2010 Sep;27(8):667-74. doi: 10.1055/s-0030-1249764. Epub 2010 Mar 11.

PMID:
20225172
2.

Therapeutic closure of the ductus arteriosus: benefits and limitations.

Mercanti I, Boubred F, Simeoni U.

J Matern Fetal Neonatal Med. 2009;22 Suppl 3:14-20. doi: 10.1080/14767050903198132. Review.

PMID:
19925358
3.

Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?

Clyman RI, Couto J, Murphy GM.

Semin Perinatol. 2012 Apr;36(2):123-9. doi: 10.1053/j.semperi.2011.09.022. Review.

4.
5.

Pharmacologic management of patent ductus arteriosus.

Bhatt V, Nahata MC.

Clin Pharm. 1989 Jan;8(1):17-33. Review.

PMID:
2643499
6.

[Ibuprofen versus indomethacin in the preterm persistent patent ductus arteriosus therapy: review and meta-analysis].

Gimeno Navarro A, Modesto Alapont V, Morcillo Sopena F, Fernández Gilino C, Izquierdo Macián I, Gutiérrez Laso A.

An Pediatr (Barc). 2007 Oct;67(4):309-18. Review. Spanish.

7.

Treatment of patent ductus arteriosus: indomethacin or ibuprofen?

Sekar KC, Corff KE.

J Perinatol. 2008 May;28 Suppl 1:S60-2. doi: 10.1038/jp.2008.52. Review.

PMID:
18446180
8.

Management of the neonate with patent ductus arteriosus.

DiMenna L, Laabs C, McCoskey L, Seals A.

J Perinat Neonatal Nurs. 2006 Oct-Dec;20(4):333-40; quiz 341-2. Review.

PMID:
17310674
9.
10.

Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indomethacin treatment.

Little DC, Pratt TC, Blalock SE, Krauss DR, Cooney DR, Custer MD.

J Pediatr Surg. 2003 Mar;38(3):492-6. Review.

PMID:
12632374
11.

Patent ductus arteriosus in the neonate.

Gersony WM.

Pediatr Clin North Am. 1986 Jun;33(3):545-60. Review.

PMID:
3520463
12.

Ibuprofen lysine for the prevention and treatment of patent ductus arteriosus.

Pai VB, Sakadjian A, Puthoff TD.

Pharmacotherapy. 2008 Sep;28(9):1162-82. doi: 10.1592/phco.28.9.1162. Review.

PMID:
18752387
13.

Preterm patent ductus arteriosus: A continuing conundrum for the neonatologist?

Evans N.

Semin Fetal Neonatal Med. 2015 Aug;20(4):272-7. doi: 10.1016/j.siny.2015.03.004. Epub 2015 Mar 25. Review.

PMID:
25818393
14.

Managing the patent ductus arteriosus: current treatment options.

Heuchan AM, Clyman RI.

Arch Dis Child Fetal Neonatal Ed. 2014 Sep;99(5):F431-6. doi: 10.1136/archdischild-2014-306176. Epub 2014 Jun 5. Review.

PMID:
24903455
15.

[First SIBEN clinical consensus: diagnostic and therapeutic approach to patent ductus arteriosus in premature newborns].

Golombek SG, Sola A, Baquero H, Borbonet D, Cabañas F, Fajardo C, Goldsmit G, Lemus L, Miura E, Pellicer A, Pérez JM, Rogido M, Zambosco G, van Overmeire B; Primer Grupo de Consenso Clínico SIBEN.

An Pediatr (Barc). 2008 Nov;69(5):454-81. Spanish.

16.

Renal safety of Non Steroidal Anti Inflammatory Drugs (NSAIDs) in the pharmacologic treatment of patent ductus arteriosus.

Fanos V, Marcialis MA, Bassareo PP, Antonucci R, Zaffanello M, Dessì A, Iacovidou N.

J Matern Fetal Neonatal Med. 2011 Oct;24 Suppl 1:50-2. doi: 10.3109/14767058.2011.607593. Review.

PMID:
21942591
17.

Genetics of patent ductus arteriosus susceptibility and treatment.

Hajj H, Dagle JM.

Semin Perinatol. 2012 Apr;36(2):98-104. doi: 10.1053/j.semperi.2011.09.019. Review.

PMID:
22414880
18.

Preterm patent ductus arteriosus: should we treat it?

Evans N.

J Paediatr Child Health. 2012 Sep;48(9):753-8. doi: 10.1111/j.1440-1754.2012.02542.x. Review.

PMID:
22970669
Items per page

Supplemental Content

Write to the Help Desk